논문KCI 등재
Correspondence to editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (15)
관련 논문AI추천
Is AMA M2 a useful serologic test for screening highrisk patients for PBC?: Editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”Nae-Yun Heo대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positiveFengchun Zhang, Haolong Li, Li Wang, Siyu Wang, Song Liu, Tengda Xu, Xinxin Feng, Xu Wang, Yanli Zhang, Yongzhe Li대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Reply to correspondence on “Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity”Atsumasa Komori대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”Do Hyun Park, Woo Hyun Paik대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Reply to: “Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis”Haeryoung Kim, Sook-Hyang Jeong대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호Clinical and serological prognostic markers in primary biliary cholangitisWilhelmi Markus대한간학회 · Clinical and Molecular Hepatology2021 · 제27권 제2호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133